• 沒有找到結果。

肝癌臨終病患身心靈之照護經驗

N/A
N/A
Protected

Academic year: 2021

Share "肝癌臨終病患身心靈之照護經驗"

Copied!
10
0
0

加載中.... (立即查看全文)

全文

(1)

ܜطࡔهᗁੰ੼ฯੰડщှঽ᜕ٗநर *ᅃࡻࡊԫ̂ጯ᜕நրӄநି଱ צ͛͟ഇĈ96ѐ9͡7͟ ࣒Լ͟ഇĈ96ѐ10͡29͟ ତצΏྶĈ96ѐ11͡1͟ ఼ੈү۰гӬĈధᐖา ࡚׶ԫఙጯੰ᜕நր 80758 ੼ฯξˬϔડ̋ڌූ5ޒ19ཱི ࿪ྖĈ(07)3162409; E-mail: joan1012.@yahoo.com.tw

ధᐖาąᜪฮӀ*

ᙯᔣෟĈքᒛćᓜ௣ঽଈć֗ă͕ăី໰᜕Ą ܕ˩ѐֽೋّཚሳ੼ا઼̰˩̂ѪЯௐ˘ ҜĂॲፂҖ߆ੰ኎Ϡཌ௚ࢍྤफ़޽΍Ăϔ઼95 ѐೋّཚሳՏ˩༱ˠ˾Ѫ˸த੼྿28.1%Ă׎̚ քᒛ੼ا˩̂ѪЯ̝ௐ˟ҜĂշẵͧதࡗࠎ 3:1ĂҫБ઼ᓁѪ˸த19.1%(Җ߆ੰ኎Ϡཌ኎Ϡ ௚ࢍྤੈშĂ2007)Ąքᒛϐഇଈ۰дϠந˯ົ ΍னূ൭ăវࢦഴᅅăเ৅̈́ཛͪඈাېĂ֭ ͷΞਕЯࠎ֗វ͕ညԼត҃யϠ࢑Ш۞ҋԧ࠻ ڱĂซ҃ӎؠҋԧхд۞ᆊࣃ(ՂĂ2004)ćѩ γĂдࢬ၆Ϡ׻ӈ૟ඕՁॡĂੵ˞ಉεҋԧଠ טਕ˧γĂࡶπॡᄃछˠ࠹఍̙։Ă˵ົٺᓜ ௣݈޺ѣཋೋ̈́ປ۝ຏĂٕЯࠎ൑ڱҹڇѪ˸ ٙ૲ֽ۞ऻᛵ҃யϠ˘ాҚ۞͕ីયᗟ(ౘĂ 2006)Ą ඊ۰ٺᓜԖ໰᜕࿅඀̚Ă៍၅זѩքᒛ࣎ ९ੵ˞ࢬᓜ֗វΑਕ਽ੜ׶̙ዋ̝γĂᔘᅮࢋ ҹڇϏۢѪ˸ٙ૲ֽ۞ऻᛵᑅ˧Ă̈́၆छˠஎ ޘ۞ᓪͣຏĂ߇͔൴ඊ۰Ᏼፄ໰᜕ѩ࣎९̝જ ፟Ăഇޞ౅࿅ᗁ᜕ဥฤˠࣶ۞ཏវЪүĂ၁ኳ ೠ೪࣎९֗ă͕ăីېڶĂ֭೩ֻ࠹ᙯঽଐྤ ੈĂଳ࣎Ҿّ۞᜕நନ߉Ăග̟࣎९̈́छᛳፋ វّ͚޺Ăͽםӄдᓜ௣࿅඀̚ᒔ଀֗ă͕ă ីЧᆸࢬ۞አዋᄃ໰᜕ĂഇధਕͽϒШ᎕ໂ۞ ၗޘЯᑕ׎ᓜ௣࿅඀Ă؃൒ࢬ၆Ѫ˸ֽᓜĂ֭ ໤౯рܓତϠ׻۞௣ᕇĄ

(2)

˘ăᓜ௣ঽଈ۞Ϡநયᗟůၙّূ൭ Ķၙّূ൭ķߏ޽னх۞ٕሕдّ۞௡ᖐຫ ᗼ ٙ ͔ ੓ ۞ ˘ ჌ ຏ ء ˯ ٕ ଐ ჰ ˯ ̙ ೚ ԣ ۞ གྷ រĂূ൭඀ޘଂᅅޘҌࢦޘăࡎ൒ٕቤၙă҃ ͷ޺ᜈٕͅᖬхд൴Ϡ෹࿅̱࣎͡(੼Ă2005)Ą ূ൭ߏᒛাϐഇଈ۰౵૱൴Ϡ۞াې̝˘Ăࡗ 85%ᒛϐঽଈົ΍ன޺ᜈّূ൭ன෪ĂࣧЯΞ̶ ࠎཚሳۡତܬϚăᒛা࠹ᙯڼᒚăᄃཚሳᑅ࢝ ̈́ ᒛ া ڼ ᒚ ൑ ۡ ତ ࠹ ᙯ ۞ ূ ൭ ඈ ˬ ჌ ( เ Ă 2003ćᛂăౘăᏥăڒĂ2004)ć׎ԛၗડ̶ࠎ ᖻវّ̰̈́᝙ّăৠགྷঽតّূ൭ඈˬ̂ᙷĂ ࡗѣ1/3ᒛϐଈ۰ࠎტЪّূ൭Ă͹ࢋᇈېࠎ൸ ѭă⪰͕ăယФĂᓚొܑଐ׶۳វᄬ֏ԼតĂ ТॡᇆᜩჂ্ăࢴᇒ̈́߿જඈ(เăౘăୖă അăᐼĂ2003)Ą ᗁᒚဥฤјࣶд఍நᒛাূ൭ॡĂᑕͽፋ វ൭̝҂ณࠎࣧ݋Ă౅࿅Ϡநă͕நăჟৠۤ ົ̈́ីّඈ࠹ᙯЯ৵ֽෞҤ׎ূ൭඀ޘĂ֭ᖣ Ϥ࠹̢໛఼྿ј˘࡭۞ᄮۢăၗޘ̈́ԫμĂͷ ֶ໰W.H.O.ˬล߱͞ёග̟ᘽۏڼᒚĂࡗ90%̝ ᒛ൭ΞᖣϤᘽۏቤྋ(ችĂ2004)ćТॡགྷϤЪآ න ዋ ̝ ᕚ Ҝ Ă ׀ ϡ ۏ ந ّ ͞ ڱ Ă т ҽ ᇳ ă ሤ ᇳăྻજăགྷϩ࿪ৠགྷו፬(TENS)ă޽ᑅă޷ ᇝו፬Ъ֐ٕ֖ˬ֧ඈϱҜৠགྷញჯĂΞѣड़ ᅃӄԼචূ൭ćѩγĂՀΞֶ໰࣎ˠಈрᏴፄ ᖤҗਨă߶ϟළඈჟڵᖤࢶĂ౅࿅পঅనࢍ۞ ࢰ ሄ ٕ Ъ ׀ ࡆ ᘤ ă ه Ң Ă ྻ ϡ ຐ ည ˧ ă எ ײ ӛă̶೸ڦຍ˧Ăͽഴቤଐჰ੓ЄĂѣड़྿ז ቤྋূ൭۞ड़ڍ(गඈĂ2004ćధĂ2004ćૺă ᆒăՂăౘă׹Ă2006)Ą ˟ăᓜ௣ঽଈ۞͕நયᗟ ᓜ ௣ ঽ ଈ Я ၅ ᛇ ז ঽ ڶ ត ̼ Ă ົ ΍ ன च ُă൏ᇋăមᑂă̙࠹ܫăϠঈăӎᄮְ၁ă ඗୕ăயϠཋೋຏඈଐჰćᐌ඾ҋԧ໰᜕ਕ˧ ۞ࢫҲă͟૱Ϡ߿Αਕಉεᄃ࣎ˠӈ૟ࢬᓜѪ ˸Ă׎щБຏצזރ਎ĂౄјˠϠ͞Шᄃϫᇾ ஄ใĂົᆧΐঽଈ၆छल໰ᜪ۞ֶᏥĂͷЯࠎ ຏזҋ̎јࠎछल̚۞࢑ፉĂ׎൑ӄă൑୕ă ൑ϡ̈́൑ᆊࣃ۞ڷಉຏڵ൒̿੓Ăጱ࡭ҋ಴Ҳ ར(ՂĂ2004)ĄଐဩّҲҋ಴ӈ࣎९дࢬ၆˘ன х۞ଐဩԛј࢑ࢬ۞ҋԧᆊࣃຏצĂົ΍னӎ ؠҋԧă൑͹֍ă൑ӄຏă˘൑ߏ఍̈́൑ڱ఍ நְІඈͅᑕćΞਕࣧЯࠎ֗វ͕ည৴ใăΑ ਕᅪᘣăεརăεୀăٕ৿ͻᄮТ̈́а㒝ඈЯ ৵(੼Ă2005)Ą ၆ѩĂᗁ᜕ဥฤᑕАޙϲฟٸăܫЇ۞ڼ ᒚّᙯܼĂଳ࡝ౖ͕ҡĂТந͕໛఼ഴᅅঽଈ ۞ڷಉ̈́൏ᇋຏćТॡͽ႙ซّ͞ёĂםӄঽ ଈᑕϡྤ໚ֽޙϲҋԧૻޘĂᆧΐ׎၆ڼᒚ۞ ણᄃ፟ົĂ֭ᗃ୻યᗟĂͽቁᄮΞҖ۞ྋՙᏱ ڱĂࢎؠ׍វϫᇾ͔ጱ;ኜҖજĂᖣϤҖજ۞ јಶຏ̈́၆ᒖဩ۞ೠଠĂΞᆧΐଈ۰۞ҋԧᆊ ࣃຏćТॡ౅࿅ҋԧଣ৶׶͕நڼᒚĂ͔ጱଈ ۰ᄃछᛳۡତ໛఼ăܑ྿׎̰͕ଐჰĂֹຏצ זజຑᄃజତৼĂซ҃ॆৼ׶ۺؠҋ̎(ՂĂ 2004ćܭăᛂăᖡĂ2004)Ą ˬăᓜ௣ঽଈ۞ីّયᗟ ីّؠཌྷࠎ࣎ˠ၆Ϡ׻̚ᆊࣃٙિ޺۞ܫ ه ٕ ܫ Ј Ă ົ ᇆ ᜩ ࣎ ˠ ۞ ఍ ְ ၗ ޘ ă Җ ࠎ ܑ னăϠ߿አዋԫμᄃˠᅫᙯܼĂࠤҌ͕֗ઉ૵ (ՆĂ2004)ćᓜ௣ଈ۰૱Я়ঽЯ৵Ăົ݇ऴٕ ৔ᗼ၆࿅Νăன၁ăϏۢ̈́Ϗֽ̙അѣ࿅۞ኳ ႷĂͷજອঽˠ۞ҋܫᄃ؟ିܫЈĂТॡயϠ ˠ ᅫ ᙯ ܼ ۞ ૪ ྋ Ă ̈́ ε Ν ࿅ Ν ѣ ड़ ۞ ᑕ ၆ ඉ ர Ă Я ѩ ૟ ົ ய Ϡ ᅮ ࢋ ౖ ҡ ă ؟ ି ă ፾ ϲ ҋ ͹ ă ᒔ ଀ ֖ ૉ ҋ ֗ ໰ ᜪ ۞ ྤ ੈ ă ણ ᄃ छ ୉ ߿ જ ă Ԇ ј Ϗ Ⴝ ̝ ְ ׶ Ϡ ׻ Ї ચ ă ྋ ՙ ໂ ბ ൭ ࡴĂᄃຏצזҋ൒ϒШ۞ၗޘඈីّᅮՐ(ౘĂ 2006)Ą

(3)

ᗁ ᜕ ဥ ฤ д ី ّ ໰ ᜕ ˯ υ ื Ӏ ϡ Ъ ү ͞ ё Ă ͽ ঽ ଈ ࠎ ̚ ͕ ҂ ณ Ă ౅ ࿅ ෞ Ҥ ̈́ ͚ ޺ ԫ μĂֶፂ࣎ˠ̙Т۞ᅮՐĂҥͽ͕நăۤົ̈́ ីّ͞ࢬ۞םӄĂֹଈ۰೩ѝϒෛăତצ֭ࠎ Ѫ˸ઇ໤౯ĂТॡώ඾චهᙯᘃ۞ჟৠĂםӄ ଈ۰ܑ྿ຑˠăజຑăΒटᄃᆵ़۞ຏצĂֹ ׎ਕૉۺؠϠ׻׶Ԇј͕ᙸ(ౘĂ2004ćGalek, Flannely, Vane, ō Galek, 2005; Hunt, Cobb, Keeley, & Ahmedzai, 2003)ćѩγĂםӄଈ۰ቤ ྋ͕֗൭ࡴă̰࠷Ϡ׻౵௣ᆊࣃĂቁᄮ၆ҋԧ ᄃ΁ˠăҋԧᄃ˯ޓٕٙܫЈ۞ৠ̝ม۞࠻ڱ ׶ᙯܼĂТॡྋՙᄃ΁ˠ۞࿣ᅣ̈́ཋೋຏĂ֭ ౅࿅؟ିܫЈᒔ଀ԓ୕׶̰д͚޺˧ณĂವՐ Ϡঽ൭ࡴᄃϠ׻ᆊࣃ۞ᙯܼĂ࠰ࠎࠎីّ໰᜕ ̝ࢦᕇ(Albinsson & Strang, 2002)ĄЯѩĂᗁ᜕ ဥฤΞᖣϤዋॡ೩ֻଈ۰ቤྋЧᆸࢬયᗟ̝න ዋ໰ᜪĂܳซछᛳม̢જĂ྿זщှච௣໰᜕ ̝౵௣ϫ۞Ą ͳАϠĂ41໐Ă੼ᖚலĂܫЈҢିć̏૓ ֈѣ˟Щ̄̃Ă໛఼ᄬ֏઼ăέᄬĂଂְՠ֘ ᜕࣒̍үкѐĂѣ٩ඵ̈́ಅ੧௫ၚĂͭᏐᎮଈB ݭ ք ۆ Ă ϓ Ꮠ ݋ ѣ Ꭴ Ԍ ঽ ঽ Ϋ ć छ ̚ གྷ ᑻ ̈ ૵Ă͹ࢋགྷᑻֽ໚ࠎᎮঽ݈᎕ᄊ׶੨ઊдᗁੰ ፉЇ᜕ҥ̍үćҝੰഇม͹ࢋ໰᜕۰ࠎ੨ઊ̈́ ׊̃Ăछ୉ᙉ֍ဦ˘Ą ˘ăঽΫ̈́Րᗁགྷ࿅ ࣎९ଈѣBݭքۆĂҭϏ޺ᜈܝ෧੠ᖸڼ ᒚĂઊѣຏ݂াېĂ൑ࢦ়̂ঽĄٺϔ઼2007 ѐ2͡Яཛණ̈́Π˯ཛొ್൭̙ዋҌߙᗁੰՐ ෧ Ă གྷ Ϥ ࿪ ཝ ᕝ ᆸ ̈́ ଳ ะ ք ௡ ᖐ ௟ ࡪ ̷ ͯ ᑭ រĂቁؠᎮଈքᒛ֭ٺܝ෧ڼᒚĄ3͡8͟΍ன ૻধཛ൭̈́ᐝຶ̙ዋĂާ෧ཛొ࿪ཝᕝᆸᑭߤ ൴னքཚሳ৔ෘ΍ҕćღާซҖքཚሳજਔং ๫ڼᒚޢˢੰĄ3͡14͟ତצௐ˘Ѩٸडቢڼ ᒚĂ΍ன⪰͕ăယФ̙ዋাېĂ߇١඗ГѨڼ ᒚĂٺ3͡17͟াېԼචޢ΍ੰܝ෧੠ᖸĂТॡ ତצᏐ̓ޙᛉವՐ̚ᗁ̈́ΩᙷᒚڱଠטাېĄ3 ͡27͟ᚑࢦཛ൭Ъ׀ᗕ˭۳ূ൭ă൑˧ГѨˢ ੰĂཛొ࿪ཝᕝᆸᑭߤ΍ཛͪć4͡1͟൴னк ఍੻ᖼொᒛ௟ࡪĂགྷᗁरШछᛳ̈́࣎९ޙᛉщ ှᒚ᜕ĂТຍົ෧щှဥฤĂٺ4͡6͟ᖼˢщ ှঽٗᜈڼᒚĄ ˟ă᜕நෞҤ ᜕நഇมҋϔ઼2007ѐ4͡6͟Ҍ4͡24͟Ă ଳ͹᜕᜕ந͞ёĂӀϡ֗វෞҤăົኘ̈́៍၅ छल̢જඈ͞ёќะ࣎९ྤफ़Ă֭ྻϡᘲͩዋ ᑕநኢߛၹĂෞҤ࣎९۞ઉ૵યᗟĄ Ğ˘ğϠநᆸࢬ 1.উЪ ˢੰീณϠ׻ᇈ෪Ă͕ྯĈ84Ѩ/minăײ ӛĈ12Ѩ/minăҕᑅĈ120/70mmhgĂα۳ϐ୘ ϩቲ໢ືĂѣᇅّĂ޽ϥ຋ҕგГ·๱ॡมࡗ1-70໐ Bݭքۆ ဦ˘ छ୉ဦᙉ 66໐ ᎤԌঽ 45໐ 43໐ 41໐ քᒛ 40໐ 13໐ 9໐

(4)

2ࡋĄਔຨఢޠͷᘦؠĂଳ਒ёײӛĂݭၗఢ ޠĂ᝘෧ᗕ઎ײӛࢰ୻႟Ă਒ొCXR൑ওማĄ4 ͡7࣎͟९͹෦ཛొ್൭Ă៍၅֗វ΍ன൸ѭă α۳ϐ୘ДҽăײӛൺܳᇈېĂѩॡീณϠ׻ ᇈ෪Ă͕ྯĈ102Ѩ/minĂײӛĈ22Ѩ/minĂҕ ᑅĈ140/90mmhgĄ 2.ᒉዳ ࣎९γ៍ពሴĂᓚᐙΌౝĂ֗੼169cmĂវ ࢦ Ꭾ ঽ ݈ 69kg(BMI: 24.16%)Ă Ꭾ ঽ ޢ 51kg ( B M IĈ 1 7 . 8 6 % ) ഴ ᅅ ŵ 1 0 % Ă Ϩ క Ϩ Ĉ 2 . 4 mg/dLĂᛳᚑࢦᒉዳ̙։Ąˢੰ݈฼ࢴઐ҇ᙷͷ ߄ࢴĂՏᐠࡗซࢴ1༦Ϩฺćˢੰޢˬᐠϒ૱Ă Տᐠࡗซࢴ1༦ංฺĂઊЯཛొණ൭҃̒ᕘࢴ ᇒĂ͹෦Ķև̄˘൭੓ֽಶ՟ࡤ˾ĂЫ̙˭Ї ңڌҘķĂ໰ົᒉዳरĂෞҤٙᅮሤณ1800̂Ι/ ͇Ă҃࣎९၁ᅫᛷפሤณࡗ1500̂Ι/͇Ą 3.ଵڴ Ꭾঽ݈ଵڴΑਕϒ૱Ăࡗ1-2͇ྋ˘Ѩ̚ณ เҒహܮćྋԌึၰĂԌณࡗ1500ml/͇ĂӔเ ͷ୻႟ĄˢੰޢՏ2-3̈ॡྋԌ˘ѨĂྋԌึၰ ൑፵լຏĂԌณࡗ200ml/ѨĂӔਮነҒćͷЯֹ ϡ๜પᙷͤ൭጗Ăጱ࡭΍னܮ৪ଐԛĂ᝘෧བ ᛅજઐၙࡗ1-2Ѩ/̶ᛗĂΣ෧ཛొ΍னခࢰĂࡗ Տ2-3͇ྋ˘Ѩ̚ณเർܮĂᆧΐహܮ጗ֹϡ ޢĂাېᒔ଀ԼචĄ 4.߿જᄃЃि ˢੰ݈͟૱Ϡ߿੓ا࠰Ξ፾ϲԆјĂᎮঽ ݈дՠ᜕࣒֘ᇄ̍үˣ̈ॡ/͟Ă˭঱ޢ൑ྻજ ௫ၚĄˢੰޢ҉҇ਕ˧ෞҤĂᗕ઎˯۳҉˧Ĉ5 ̶Ă˭۳҉˧Ĉ3̶Ăα۳҉҇ኳ๴ᗫహĂᙯ༼ ൑តԛĂ˭ԖтೂՎၗ̙ᘦᅮԬ޺Ă͟૱໰᜕ ϤछˠםӄĄҝੰഇมЯ෍ऴăཛණ̈́ᗕ˭۳ ূ൭ࡗ7-8̶Ă߿જຍᙸઐҲͷజજĂ͹෦ĶՏ Ѩ ᖙ ֗ ̈́ ߿ જ ॡ ౌ ൭ ז ̙ Җ Ă ԧ Ϊ ຐ ዁ ඾ ಶ рķĂ߇̂ొ̶࠰ۻԖЃिĄፂ͹෦дछ؆Ⴢࡗ 5-6̈ॡĂஎՕ̙צ̒ᕘĄˢੰޢ៍၅؆্ࡗჯ ޺5-6̈ॡĂ4͡9͟؆্Яূ൭̒ᕘĂ่ჯ޺ࡗ 2-3̈ॡĂϨ͇ᄃ׎ົኘॡពিࢽĂڦຍ˧̙ะ ̚Ăᗕீ΍னโீ઻ͷ໭ᛒ̙щĄ 5.ຏᛇᄃۢᛇ ࣎९ෛă᝘ăקă๥ăᛈă໢ăᑅᛇਕ୻ ຾ᏰᙊĄ͹෦ٺ2007ѐ2͡൴ঽޢĂགྷ૱ຏזΠ ˯ཛొ΍ன್ו൭Ăূ൭ૻޘ̈́޺ᜈॡม࠰̙ ˘ؠĂՏѨ౅࿅Ⴢ্ٕԡ˘˭ӈΞቤྋĄˢੰ ޢෞҤΠ˯ཛొ૱̙ؠॡຏז್ו൭Ă˭۳Я ᒛ௟ࡪ੻ᖼொĂӔனк఍ᅕ౫൭Ăͽᇴфূ൭ ณܑෞҤ࣎९ূ൭̶ᇴ4-5̶Ă៍၅ᖙ֗̈́߿જ ॡ׭Ӥͷܑଐ൭ࡴĂ͹જ͕҃̈ᓍᓍ۞ͽᗕ͘ Ԭ޺ཛొ̈́ᗕ˭۳ĂᗕϫღౕĂ࠺ᐝღሸĂ֗ វئѡјኇѼېĂ͹෦ূ൭޽ᇴΐᆐҌ7-8̶Ă ՏѨূ൭ॡมჯ޺ࡗ15-30̶ᛗĂ៍၅࣎९ٽצ ঽވ׹ዎᓏࢰ̒ᕘ҃ព଀තঈᇷᛒĄ 6.វ୵࿪ྋኳ ࣎९ቲҒᜐเĂϩቲᇅّإΞҭព઀ᒌĂ ˾ටᕆቯԆፋĂα۳൑ͪཚĂཛొ΍னཛͪĂ ീ ณ ཛ ಛ 1 0 4 c m ć ٩ ҕ ᑭ រ Ă ҕ Ԍ ৵ ധ Ĉ 20mg/dLă҉῔ᅕĈ0.9 mg/dLĂϠ׻ᇈ෪ᘦؠĂ ൑ໂޘ˾ഽă̙щăᛒજ̈́ယФĄ 7.ৠགྷ̶̰̈́ک ࣎९ຍᙊ୻ᏹĂ၆ٺˠăॡăг۞၆ኘӮ Ξ ϒ ቁ а ඍ Ă ৠ གྷ ۞ ຏ ᛇ ൑ ᅪ ᘣ Ă α ۳ ൑ ͪ ཚĂทĈ131 meq/dLă࿔Ĉ3.1 meq/dLăถĈ7.5 mg/dLćᓁᓙࡓ৵Ĉ26.2mg/dLĂϩቲ΍னเ ৅ćវ໢ჯ޺д36˚C-36.8˚CĂ˭۳ϐ୘ٽᒅ ҽĂΞдΐૻజᄏޢа໢Ą 8.ᄮۢ ࣎९ؠШ˧ָĂڦຍ˧ะ̚Ăܜăൺഇ੃ ጸ։рĂΞϒቁҿᕝ̈́аᑕĂҭূ൭ॡ၆ᗁ᜕ ˠ ࣶ ྙ ય ૱ ຏ ̙ ࡝ ໭ Ă ព ଀ ྵ ୶ ႐ ̈́ ١ ඗ а ᑕĄ 9.ّůϠത ࣎९ϫ݈̏૓Ăֈѣ׌Щ̄̃ĂᑭෛϠത ጡءγ៍Αਕϒ૱Ą Ğ˟ğ͕நᆸࢬ

(5)

1.ҋԧໄه ࣎ ९ ܑ ϯ ѐ ᅅ ॡ ຑ ە ͷ ၆ छ ल ྵ ̙ ࢑ య ЇĂдγڈ̓кĂˠቡໂָĂπ͟ಈᝌײڈ͔ ҡჸົĄᎮঽޢЯཛͪăเ৅ඈγ៍ֹ׎ຏז ൑ӄăᇙޤĂഅШ९؍ܑϯĶ̙ࢋӘ෦ڈ̓ԧ ҝ ੰ ۞ ঐ ि Ă ன д ఺ ᆃ ᔟ Ă ̙ ຐ జ ΁ ࣇ ࠻ ֍ĄķĂ֏ኘมܑଐརွĂࢰณត̈ć࿃ѣᏐ̓ ଣෛĂϲӈٛజପᄏࡎ੓̝ཛొͷౕீЃिć ҝੰഇมᔿ͌΍ঽٕٗᄃ׎΁ঽଈ̢જĂခᐽ γ΍߿જ૱ͽ֏ᄬ຤๫ٕ١඗аᑕĂ͹෦Ķև ̄ණ̂ͷБ֗൴เĂᛇ଀ҋ̎рည⾩ގĂ֕΍ ঽٗົᑂזҾˠĊķĄՀЯࠎ˭۳෍ऴ൑˧Ă˭ Ԗтೂăᎋ߾̈́ᖙ֗ඈ͟૱Ϡ߿࠰ᅮࢋҾˠם ӄĂᛇ଀ҋ̎ည࣎ᆿˠĂ࣎९ܑϯĶͽ݈̦ᆃ ְౌΞͽҋ̎ઇĂனдݒాЫฺౌࢋҾˠᔼĂ ᛇ଀ޝϴᓚă՟ѣϡĂ૱౫໭Ҿˠᛇ଀ޝ̙р ຍޥĄķĄࣧ൑؟ିܫЈĂҭЯछˠ᎞ܫҢି҃ ྫྷ ᐌ Ă ࣎ ९ ൑ ӄ ۞ ܑ ϯ Ķ ߏ ̙ ߏ Я ࠎ ̙ ૉ ਴ ྕĂٙͽҢয়̖ົᘂჳԧĂឰԧϠঽĉķĶѪ˸ ఺୧ྮՏ࣎ˠౌࢋ֕ĂҭـϠޢ˘࣎ˠ̙ۢົ ࿃ז̦ᆃְĉҢয়ົ̙ົᑒԧĉķ 2.֎ҒΑਕ ࣎९ௐ˘֎Ғࠎ41໐շّćௐ˟֎Ғࠎˮ ͈ăͭᏐă׊̄ăՠ᜕࣒֘ᇄࣶ̍ćௐˬ֎Ғ ࠎᒛাଈ۰ĄֶEriksonˠᙷ൴णล߱நኢĂ࣎ ९఍ٺ׍Ϡய˧ٕᏂ୧ຏ̝јˠഇĂѩล߱ࢦ ᕇдϠயăିዳᇬֈ̄̃Ą࣎९ѐᅅॡ૱ᄃ̓ ˠಅ੧ăኯ౾ć͹ଠᇒૻͷઇְާᛒĂٽЯְ ଐ̙ึ͕҃ᄃ੨ઊۋӝĂ၆ޅ̄ྵنෛĂϫ݈ ᎮঽޢϠய˧ઃ႖Ă൑ڱౖҡ̈́໰᜕ϒࣃܦߋ ഇ̄̃ВТјܜĂд྽ᇇůநຐůჟৠԧ۞̰ ࠷˯Ăປ۝ͷҋయߏεᖚͭᏐ̈́ܧநຐˮ͈Ă അ ݖ ๋ ͹ ෦ Ķ ன д ҝ д ᗁ ੰ Ă ՟ Ᏹ ڱ ໰ ᜪ ޅ ̄Ă̙ۢ྽΁ࣇдछѣ՟ѣ޷ॡЫฺĉķĶϠঽ ̝ޢ՟̍үĂ͉͉ࢋ࢑యछ྆ྫྷᗁੰ۞ְĂည ᜐᒍ׌ᐝ፵Ăᛇ଀ޝ၆̙੓сĊķĄѩγĂ࣎९ ᎮঽޢᔵЯ෍ऴă˭۳൑˧൑ڱҋԧ໰᜕Ăҭ ׎͹෦၆ঽڶ·̶˞ྋĂΞϒෛҋ়֗ঽĂϏ ΍ ன ࿅ ޘ ഇ ޞ Ă ൒ ҃ ៍ ၅ ࣎ ९ ኘ ̈́ Ѫ ˸ ᛉ ᗟ ॡĂ֏ኘมពڦຍ˧̙ะ̚Ăܑଐ൏ᇋĂઊ΍ னᇙޤଐჰĄ 3.࠹ֶ̢Ꮵ ҝੰഇม͹ࢋ໰᜕۰ࠎ९؍Ăߏ࣎९Ϡ׻ ̚౵ࢦࢋ̈́ѣຍཌྷ۞ᙯܼˠĂ࠹ᙯ۞ᗁᒚՙඉ ࠰ Ϲ Ϥ ९ ؍ ՙ ؠ ć ၆ ٺ ९ ؍ ௟ ͕ ͷ ࡝ ͕ ۞ ࠻ ᜕Ă࣎९࠹༊ຏજᄃຏᔁĂ࠹၆ٺѐᅅॡҋ̎ ۞ᇷᛒතঈĂ൑ڱචޞ੨ઊĂஎஎ۞ຏזປ۝ ᄃཋೋĂĶѐᅅ۞ॡ࣏තঈᇷᛒĂ૱ྫྷ͉͉ӝ ߛĂனдсᔘᙸຍ఺ᇹ໰ᜪԧĂᛇ଀၆сѣᓪ ͣຏĄķćᎮঽޢ࣎९ࢬ၆ҋ̎ӈ૟ـϠ൑ڱ ໰ᜪछलຏזҋయĂ҃ͷचُፉ͕̄̃൑ڱந ྋѪ˸ຍཌྷĂϏ͹જШ९̄̃ྋᛖঽڶត̼Ą ҝੰഇม៍၅९̄̃ଣෛѨᇴࡗ1-2Ѩ/ฉĂଣෛ ഇมкӱٺԖय़ٕԖԍĂᄃ࣎९̢જழᗓĂྵ ͌͹જᏐܕ̈́םӄ໰᜕Ă࿃ঽଈূ൭ॡܑଐព ຖใĄ९؍ܑϯĶᔵ൒ۢ྽ঽଐు႙ೋ̼Ăҭ ΁՟ᄲĂԧ˵̙ۢ྽ྍިᇹฟ˾ય΁ޢְࢋި ᆃᏱĉ̙ۢ྽रͭΞ̙Ξͽᑒѓĉķ ඊ۰ֶፂᘲͩዋᑕநኢߛၹăྻϡ֗វෞ Ҥă៍၅ă໛఼̈́ົኘඈԫμტЪᕩৼ΍࣎९ ˬ࣎͹ࢋઉ૵યᗟĂ̶Ҿࠎၙّূ൭ăଐဩّ Ҳҋ಴͕̈́ីӧᕘĂಶЧઉ૵યᗟ۞᜕நࢍထ ̶Ҿೡࢗٺܑ˘ƂܑˬĄ ᒛϐূ൭ߏ˘࣎ኑᗔͷкᆸࢬ۞યᗟĂົ צ࣎ˠ͕நăۤົ̈́ីّඈᆸࢬ۞ᇆᜩĂ౅࿅ ܧ็௚ͤ൭ᘽۏ۞͞ёĂтଳTENSăᖤҗਨჟ ڵᖤࢶăࢰሄ̈́؟ିर۞ᅃӄĂֹ࣎९۞ূ൭ ޽ᇴځពഴᅅĂѩᄃगඈˠ(2004)ăధ(2004)ă

(6)

ૺඈˠ(2006)ٙ೩΍׀ϡۏநّ̈́Ωᙷᅃӄᒚ ڱĂΞѣड़྿זቤྋূ൭ड़ڍ࠹ӚЪć໰᜕ഇ ม˵ྻϡ࣎९إх۞ొЊҋԧ໰ᜪਕ˧Ăםӄ ׎ͽѣࢨ۞ਕณ̈́ΑਕֽԆј͟૱Ϡ߿߿જĂ ᖣѩᆧซ࣎९۞ҋ಴ր௚̈́ҋԧᆊࣃຏצćГ གྷϤೈԔ႙ซ͞ёĂವԱ׎Ϡঽ൭ࡴ̝ຍཌྷĂ ֹ࣎९дҝੰഇมຏצזజ؍̄׶׊̃ᆵ़ă ᛝ़ҋ̎ăజຑ׶ຑˠ۞གྷរĂ࣒֭ೇ׎ಉε ۞ छ ल ј ࣶ ม ̝ ̢ ຑ ᙯ ܼ Ă ֹ ࣎ ९ ѣ ݌ ঈ ࢬ ၆ăତצă֭໤౯ҋ̎۞Ѫ˸Ą ༊ᒛϐଈ۰ࢬᓜϠ׻۞ႽᐝĂߏ౵ᅮࢋᗁ ᜕ဥฤˠࣶ̈́छˠ۞͚޺ᄃᙯຑĂᖣϤ೩ֻѣ ܑ˘ ઉ૵યᗟ˘Ĉၙّূ൭Ɲքཚሳᑅ࢝Ъ׀੻ᖼொ ͹މ៍ྤफ़ ᜕நϫᇾ ᜕நନ߉ ᜕நෞࣃ ҖࠎෞҤ (ௐ˘ᆸѨෞҤ)Ĉ ͹៍ྤफ़Ĉ 1. 4/7ĶՏѨᖙ֗̈́߿જॡౌ൭ז̙ҖĂԧ Ϊຐ዁඾ಶрķĄ 2. 4/7Ķև̄˘൭੓ֽಶ՟ࡤ˾ĂЫ̙˭Ї ңڌҘķĄ މ៍ྤफ़Ĉ 1. 4/7ূ൭ॡ΍ன൸ѭăα۳ϐ୘Дҽăײ ӛൺܳĂ͕ྯĈ102Ѩ/minĂײӛĈ22Ѩ /minĂҕᑅĈ140/90mm-HgĄ 2. 4/7࣎९߿જຍᙸઐҲĂ၆ᖙ֗̈́߿જଳ జજĂͷܑன΍᜕ّܲҖࠎů͹જͷ̈ ͕ᓍᓍͽᗕ͘Ԭ޺ᗕ˭۳̈́ཛొĄ 3. 4/8ۻԖЃिॡ൴΍׭ӤĂᓚొܑଐ൭ ࡴĂᗕϫღౕĂ࠺ᐝღሸĂ֭΍னᛋԦ ّҖࠎůᗕ͘ٱҝཛొĂ֗វئѡјኇ ѼېĄ 4. 4/8ূ൭ॡٽצᓏࢰ̒ᕘ҃ពᇷᛒٽޤĄ 5. 4/9Яূ൭̒ᕘĂ؆Ⴢ่2-3̈ॡĂϨ͇ ពিࢽĂڦຍ˧̙ะ̚Ăᗕீ΍னโீ ઻ͷ໭ᛒ̙щĄ 6. 4 / 6 - 4 / 1 8Π˯ཛొ૱̙ؠॡຏז್ו ൭Ăᗕ˭۳Яᒛ௟ࡪ੻ᖼொĂӔனк఍ ᅕ౫൭Ă4/7ͽূ൭̶ᇴᇴфณܑෞҤཛ ొূ൭޽ᇴ7-8̶Ă޺ᜈূ൭ࡗ15-20̶ ᛗĂ၆᜕நˠࣶྙયຏז̙࡝໭ă୶႐ ̈́١඗аᑕĄ ᇆᜩЯ৵ (ௐ˟ᆸѨෞҤ)Ĉ 1.͹ࢋו፬Ĉքཚሳᑅ࢝ă˭۳ᒛ௟ࡪ੻ ᖼொĄ 2.࠹ᙯו፬Ĉᖙ֗̈́߿જॡౄјொજّূ ൭Ą 3.౺ዶו፬Ĉ࿅Νূ൭གྷរĄ 1. 4 / 9࣎ ९ ਕ ૉϒቁͽᇴ фূ൭ณܑ ෞҤ֭˾ᐝ ܑ྿ূ൭ొ Ҝăݭၗ̈́ ̶ᇴĄ 2. 4/12࣎९Ξ ͽд९؍ם ӄ˭Ăϒቁ ેҖҌ͌׌ ีܧᘽۏূ ൭ଠט͞ڱ ቤྋূ൭Ą 3. 4 / 6 - 4 / 2 0࣎ ९͹෦౅࿅ ᘽۏ̈́ܧᘽ ۏ̝ূ൭͞ ڱĂፋវূ ൭޽ᇴΞϤ 7 - 8̶ ࢫ Ҍ 1-2̶Ą 1. 4/6-4/23౅࿅ՏѨֹϡᘽۏޢ30̶ᛗĂ̈́ Տ׌̈ॡ͹જ៍၅࣎९ᓚొܑଐă۳វ જүăϠ׻ᇈ෪ត̼Ă͹જ൴னূ൭ય ᗟĂ֭ͽᇴфূ൭ณܑෞҤ࣎९ূ൭ૻ ޘăᐛதăّኳă޺ᜈॡมĂϒቁࡔᐂ ٺূ൭ෞҤܑĄ 2. 4/6ෞҤΐࢦূ൭ૻޘ̝ࣧЯĂ֭םӄ׎ ቤྋтĈିጱ९؍Տ׌࣎̈ॡĂӀϡLݭ ᖙ֗ڋᅅߘᖙ֗ăᕚҜĂͷᖙ݈֗೩ѝ Әۢᖙ֗ՎូĂ֭ͽٱڋዋ༊͚ᨓཛొ ̈́˭۳ĂᔖҺ҉҇஝ԵĄ 3. 4/6-4/18Տ͟Ⴢ݈ͽ࣎९ٙᏴፄ̝ᖤҗਨ ჟڵĂᖤࢶ࣎९30̶ᛗ-1̈ॡĂֹ׎ٸ ᗫ͕ଐĄ 4. 4/8ᄃ࣎९੅ኢ̈́ෞҤޢĂିጱՏ͟׌Ѩ ซҖஎײӛٸᗫྻજĂࡗ10-15̶/ѨĂ౅ ࿅ӛঈФৼ͞ёٸᗫ҉҇ćТॡЪ׀׎ ઐр̝̂ҋ൒഑ڒࢰሄĂනቤ׎ଐჰ֭ ᖼொ၆ূ൭̝ڦຍ˧Ą 6. 4/10࣎९ূ൭ॡϡTENSו፬Ъ֐ϱҜͽ ቤྋূ൭ĂТॡିጱछᛳВТ޽ᑅ޷ᇝ ֖ˬ֧ϱҜĂࡗ15-20̶/ѨĂঐੵ҉҇ღ ૺĂܳซҕ୵ೈᒖĄ 7. 4/7-4/10ᗁ᜕ဥฤֶፂ࣎९۞ূ൭ෞҤĂ ૟૱ఢᘽۏMorphrine 10mg q6h po qdአ ፋјMorphrine 10mg q4h po qdֹϡĂ֭ ྎ௟Ш࣎९̈́छᛳྋᛖᘽۏЩჍă጗ณ ֹ̈́ϡ͞ёĂֹ׎ਕ੨Ъ޷ॡڇᘽĂ̈́ ഴᅅֹϡᘽۏ̝ႷᇋĄ 8.࣎९γ΍ણᄃঽٗ߿જ݈Ăֶᗁឤග̟ Morphrine 10mg po statĂͽ࿰֨ূ൭൴ ϠĄ 9. 4/7-4/22͹જଣෛăᙯᘃ׶้᝘࣎९ূ൭ ॡ໭ᛒ̈́चُѪ˸ຏצĂགྷТຍᓑඛ؟ ିरᄃ׎ົኘĄ 1. 4 / 9࣎९͹જͽ˾ ᐝܑ྿ཛొٺᖙ֗ ॡӔன5-6̶್ו ൭Ą 2-1. 4/10࣎९౅࿅ᇫ ٸ ̂ ҋ ൒ ഑ ڒ ࢰ ሄĂᄃ९؍ϒቁે ҖஎײӛྻજĂ͹ ෦ূ൭̶ᇴϤ5-6 ̶ࢫז3̶ĂТॡ ܑϯĶࢰሄ˘᝘Ă ឰፋ࣎ˠౌනڇͷ ͕ଐٸᅅᗫ˞Ąķ 2-2. 4/12࣎९д९؍ םӄ˭Ξϒቁ޽΍ Ъ֐֖̈́ˬ֧ඈϱ ҜĂ֭ٺূ൭ॡϒ ቁેҖϱҜ޷ᇝĂ Тॡܑϯূ൭̶ᇴ Ϥ 4 - 5 ̶ ࢫ ז 1 - 2 ̶Ą 3. 4/20࣎९͹෦౅࿅ ֹϡͤ൭ᘽۏ֭ᅃ ӄTENSăᖤҗਨ ჟڵᖤࢶ̈́ࢰሄڼ ᒚĂБ֗ূ൭̶ᇴ Ϥ 7 - 8 ̶ ࢫ ࠎ 1 - 2 ̶Ą

(7)

ड़۞࣎Ҿ᜕ّநନ߉Ăֹώ͛࣎९дᓜ௣࿅඀ ̚ᒔ଀֗ă͕ăីЧᆸࢬ۞አዋᄃ໰᜕Ă֭д ிˠ۞ຑᄃᙯᘃ˭ᒔ଀ච௣ĄаᜪѩѨ໰᜕࿅ ඀ĂЯ࣎९̄̃ྵ͌ҌੰଣෛĂඊ۰൑ڱ׍ѣ ·ྈ۞ॡมĂஎˢଣ੅׎̄̃၆ͭᏐѪ˸۞࠻ ڱć҃ᗁ᜕ဥฤјࣶ˵ЯᓜԖ̍үᓄѓĂ૱д ࣎९ـϠޢӈඕՁ໰᜕ĂྵटٽنரـϠ۰छ ᛳ ͕ ந ۞ ຏ צ ̈́ ᅮ Ր ć ඊ ۰ ٺ ࣎ ९ ـ Ϡ ޢ ˘ ฉĂ౅࿅࿪ྖᄃ९؍ᓑᘭົኘĂᙯᘃ׎ଐჰͅ ᑕĂፂܑϯछᛳมᔵ൒̏ତצ࣎९ـϠְ၁Ă ҭ̪൑ڱ֕΍ݖ๋ଐჰć߇ඊ۰ޙᛉĂд࣎९ ـϠޢΞ౅࿅ۤ̍ˠࣶӀϡ࿪ྖ੠ᖸĂᖣϤົ ኘ ͔ ᅳ छ ᛳ ቤ ྋ ׎ ݖ ๋ ͅ ᑕ Ă ֭ ග ̟ ͕ ந ͚ ޺ćТॡĂՀΞͽᖼ̬࠹ᙯ͚޺ّဥវᅃጱĂ ٕགྷϤاछщှ໰᜕͞ёซҖ᏷୉ᙯᘃĂᖣͽ ྿ ז Б ˠ ă Б छ ă Б ඀ ă Б ฤ ۞ ౵ ੼ ໰ ᜕ ݡ ኳĄ Җ߆ੰ኎Ϡཌ኎Ϡ௚ࢍྤੈშ(2007Ă7͡22 ͟)Ćϔ઼95ѐѪЯ௚ࢍඕڍၡࢋĆშྮၡ ҋhttp://www.doh.gov.tw/cht2006/index_po-pulace. aspx ܑ˟ ઉ૵યᗟ˟ĈଐဩّҲҋ಴Ɲ֗វ͕ည৴ใăεརѣᙯ ͹މ៍ྤफ़ ᜕நϫᇾ ᜕நନ߉ ᜕நෞࣃ ҖࠎෞҤ (ௐ˘ᆸѨෞҤ)Ĉ ͹៍ྤफ़Ĉ 1. 4/9 Ķα۳൑˧Ă̦ᆃְౌࢋҾˠᑒѓĂᛇ଀ҋ̎рည ᆿˠķĄ 2. 4/9 Ķͽ݈̦ᆃְౌΞͽҋ̎ઇĂனдݒాЫฺౌࢋҾ ˠᔼĂᛇ଀ޝϴᓚă՟ѣϡĂ҃ͷ૱౫໭Ҿˠᛇ଀ޝ̙ рຍޥķĄ 3. 4/12Ķ̙ࢋӘ෦ڈ̓ԧҝੰ۞ঐिனд఺ᆃᔟĂ̙ຐజ ΁ࣇ࠻֍ķĄ 4. 4/12Ķև̄ණ̂ăБ֗൴เĂᛇ଀рည⾩ގĂ֕΍ঽٗ ົᑂזҾˠķĄ މ៍ྤफ़Ĉ 1. 4/6 ᓚᐙΌౝĂቲҒᜐเĂཛొӔனཛͪĂീณཛಛ 104cm ᗕ઎˯۳҉˧Ĉ5̶Ă˭۳҉˧Ĉ3̶Ă൑ڱ፾ϲ Ԇј͟૱໰᜕Ą 2. 4/10 Ꮠ̓ଣෛॡĂϲӈٛజପᄏࡎ੓̝ཛొͷౕϫЃ िĄ 3. 4/12 ࣎९၆னхγܑ̙႕ຍĂኘ̈́γᄻԼតྖᗟॡĂܑ ଐརွăࢰณត̈Ăព଀൑ӄ̈́ᇙޤĄ 4. 4/12 ࣎९ഴ͌γ΍߿જ፟ົĂခᐽγ΍߿જĂ૱֏ᄬ຤ ๫ٕ١඗аᑕĄ ᇆᜩЯ৵ (ௐ˟ᆸѨෞҤ)Ĉ 1.͹ࢋו፬Ĉ়ঽౄј֗វγ៍ԼតĂጱ࡭֗វ͕෪৴ ใĄ 2.࠹ᙯו፬Ĉ۳វ൑˧ͷ͟૱Ϡ߿໰᜕ΑਕಉεĂயϠε ར̈́൑ӄຏĄ 3.౺ዶו፬Ĉҋᛇ൑ᆊࣃĄ 1. 4/12࣎९ٺ ९؍םӄ˭ ਕેҖᎋ߾ ̈́ซࢴඈ˟ ีҋԧ໰ᜪ ԫਕĄ 2. 4/15࣎९ਕ ͹જྻϡ౺ ዶΑਕĂם ӄঽٗҶཉ ᒖဩĄ 3. 4/15-4/20࣎ ९ਕͽ˾ᐝ ܑϯ၆ҋ̎ ̝ ϒ Ш ೡ ࢗĂ֭ਕҋ ԧତצĄ 1. 4/7-4/10ົኘॡĂͽฟٸّયྖ ͔ጱ࣎९ܑ྿၆൑ڱҋԧ໰᜕ٙ யϠ̝ڷಉຏăγ៍ត̼۞ҋԧ နೋ࠻ڱĂͽ̙Բҿ۞ၗޘĂщ ᐖ้᝘֭ТநЯҋԧ໰᜕Αਕಉ ε͔ٙ੓̝εརă൑ӄ͕ଐĄ 2. 4 / 11ᄃ࣎९੅ኢĂෞҤវ˧ధ ΞĂӀϡԖय़ॸ̈́Ԗ᛼ᅃӄซҖ ᎋ߾̈́ซࢴĂᆧૻ׎ ۳វ۞ଠ טຏćТॡᄃԠ̍ˠࣶд׎ҋҖ ᎋ߾ॡග̟Ⴭ៙ć֭੫၆ซࢴԫ μĂ೩ֻ ഼ટֹϡͽഴ͌क़Զ ຏĄ 3. 4/12ᖣϤঽٗ૵ሄ߿જĂϤԠ̍ ˠࣶ͔ጱ࣎९ĂВТጯ௫޸οە ઊᄦү֭םӄҶཉϹኖះᒖဩĄ 4. 4/13ᄃԠ̍ВТࠎ࣎९ፋநᆇ टĂ֭ዋ༊ͽҗۏପᄏཛొĂֹ ϡ዇എםӄ࣎९γ΍ણΐঽٗΙ ٛOKႇભ߿જĄ 5. 4/16ۤ̍ˠࣶᄃ࣎९ВТ̶ֳঽ ̰ٗ࠹Т়ঽ९ּĂ౅࿅ᄃঽ̓ ̈́׎छᛳ̢̝જĂซҖ়ঽགྷរ ̶ֳĂֹ࣎९ڦຍ׎΁ଈ۰۞х дĂഴᅅ׎؝፾ຏĄ 1. 4/12д९؍ם ӄ˭ٺԖ˯ҋ Җ ᎋ ߾ ̈́ ซ ࢴĂ͕ଐ೚ԣ ͷ˾ᐝܑϯ႕ ຍҋܑ̎னĄ 2. 4/15࣎९ٺϹ ኖះᄃԠ̍В ТԆјˬ࣎޸ οەઊĂ֭ͽ ׎ҶཉᒖဩĂ ࣎९ܑϯĶᔵ ൒ཙ൑˧Ăҭ ͘ ᔘ ៌ ី ߿ ۞Ăઇ΍ֽ۞ ەઊޝ႓ܪĂ ඗၆̙Ꮾγࢬ ኱۞Ąķ 3. 4/17࣎९ܑϯ Ķ ࣧ ֽ Ϡ ఺ ჌ ঽ ۞ ˠ ఺ ᆃ кĂ҃ͷԧ̙ ߏ౵ᔟă౵՟ ϡ۞ĂҌ͌ԧ ᔘΞͽભႇĂ ҋ̎Ыฺ׶ה ͰķĄ

(8)

ܑˬ ઉ૵યᗟˬĈ͕ីӧᕘƝ၆छᛳᓪͣăѪ˸൏ᇋ̈́၆؟ି۞ழᗓ ͹މ៍ྤफ़ ᜕நϫᇾ ᜕நନ߉ ᜕நෞࣃ ҖࠎෞҤ (ௐ˘ᆸѨෞҤ)Ĉ ͹៍ྤफ़Ĉ 1. 4/12ĶனдҝдᗁੰĂ՟Ᏹڱ໰ᜪޅ ̄Ă̙ۢ྽΁ࣇдछѣ՟ѣ޷ॡЫ ฺĉķ 2. 4/12ĶϠঽ̝ޢ՟̍үĂ͉͉ࢋ࢑య छ྆ྫྷᗁੰ۞ְĂညᜐᒍ׌ᐝ፵Ăᛇ ଀ޝ၆̙੓сķĄ 3. 4/12ĶѐᅅॡතঈᇷᛒĂ૱ྫྷ͉͉ӝ ߛĂனдсᔘ఺ᇹ໰ᜪԧĂᛇ଀၆с ѣᓪͣຏĄķ 4. 4/13Ķͽ݈૱ຑྫྷڈ̓΍ΝەĂ၆छ ྆՟ѣయЇຏĄķ 5. 4/16Ķߏ̙ߏЯࠎ̙ૉ਴ྕĂٙͽҢ য়̖ົృჳԧĂឰԧϠঽĉķ 6. 4/16ĶѪ˸఺୧ྮՏ࣎ˠౌࢋ֕Ăҭ ـϠޢâ࣎ˠ̙ۢົ࿃ז̦ᆃְĉ Ңয়ົ̙ົᑒԧĉķ މ៍ྤफ़Ĉ 1. 4/10 ៍၅࣎९ᄃ׊̢̃જழᗓĂ࿃ ࣎९֗វ̙ዋॡĂ׊ܑ̃ଐຖใ̙ۢ ٙନĄ 2. 4/12 ࣎९ٺົኘॡĂ੫၆ᎮঽޢϠ ய˧ઃ႖Ă൑ڱ໰ᜪछलౖ̈́ҡ̄̃ ВТјܜពҋయ̈́ປ۝Ăܑଐݖ๋Ą 3. 4/16 ࣎९Я၆؟ି̙ૉ਴ྕயϠཋ ೋຏĂचُצז؟ି᏷ୢĂֹـϠ࿅ ඀؝ಏĂ֏ኘมព൑ӄĄ 4. 4/16 ੅ኢѪ˸ᛉᗟॡĂ࣎९ڦຍ˧ ̙ะ̚Ăܑଐ൏ᇋઊ΍னᇙޤଐჰĄ 5. 4/17 ፉ͕̄̃൑ڱநྋѪ˸ຍཌྷĂ إϏ͹જШ९̄̃ྋᛖঽڶត̼Ă࣎ ९၆ٺӈ૟࿅͵՟ѣ·̶͕ந໤౯Ą 6. 4/19 ९؍ܑϯ࣎९၆ޢְϏ໤౯Ă ഇޞ؟ିםӄĄ ᇆᜩЯ৵ (ௐ˟ᆸѨෞҤ)Ĉ 1.͹ࢋו፬ĈЯܜഇ൑ڱචޞछᛳĂ҃ யϠ၆छˠ۞ᓪͣຏĄ 2.࠹ᙯו፬ĈࢬᓜѪ˸۞൏ᇋ̈́ޢְ໤ ౯ă၆؟ିழᗓĂፉ͕צזৠҢ۞᏷ ୢĄ 3.౺ዶו፬Ĉҋᛇ؝፾ຏĄ 1. 4/15࣎९Ξ ͹જܑ྿၆ छˠ۞ᓪͣ ຏ࣒֭ೇك ѩ ᙯܼĄ 2. 4/17࣎९Ξ ͹જܑϯ֭ Ϥछˠםӄ ྿јϏԆј ͕ᙸĄ 3. 4/20࣎९ਕ ͹જ҃؃൒ ۞ኘኢϠѪ ᛉᗟĂ֭ତ צӈ૟Ѫ˸ ۞ְ၁Ą 4. 4/23࣎९ਕ ͹જᄃछˠ ੅ኢ̈́щଵ ޢְ໤౯Ą 1. 4/10-4/18Տ͇30̶ᛗů1̈ॡ͹જౖҡ࣎ ९ĂޙϲܫЇᙯܼĂᖣϤᅅ೪ᗕ͘Ă̈́ீ၆ ீତᛈĂගౖ̟ҡ้̈́᝘ܑ྿ፉ͕ޅ̄Ϗֽ Ϡ߿ͻˠ໰ᜪ̈́ώ֗ಏ፾ࢬ၆Ѫ˸चُ۞ຐ ڱĄ 2. 4/13ခᐽ࣎९Ă͹જͽ˾ᐝШ९؍ܑ྿кѐ ֽҋ̎၆छलழٺ໰ᜪ۞ႆຍ̈́ຏᔁ९؍၆ छल۞;΍ĂᖣϤ͔ጱጾٱೇЪᏐ૜ᙯܼĂ ۺؠكѩ۞֎ҒĄ 3. 4/13͔ጱ࣎९ᄃ९؍ВТаᜪϠ׻Ă༊ኘ̈́ ܐඕ૓ॡВТጬ੽Ыࡴ۞࿅඀҃ᙱ࿅ஊॡĂ ̟ᅅ೪ᗕܑ͘྿ᙯᘃă૞ڦ้᝘ౖ̈́ҡĂ͔ ጱ९؍ܑ྿ຏᔁ̈́ۺؠ࣎९ࠎछल۞;΍Ą 4. 4/14׊̃ଣෛ࣎९ഇมĂםӄͽΙͯ३ᆷ͕ ଐᕇႍĂܑ྿၆࣎९۞ຑຍ̙̈́଺Ą 5. 4/14ᄃԠ̍ٺϹኖះᒉౄ໢ᛟϡᐠᒖဩĂם ӄ࣎९БछВТϡᐠĂٮᛷБछ჊໰ͯĄ 6. 4/15؟ିरᄃ࣎९̈́׊̃ВТ៍ካБछ჊໰ ͯĂТॡаᜪ׊̃јܜ۞೚ԣְІĄ 7. 4/17࣎९ܑ྿ຐᄃछᛳВТ΍ྼ͕ᙸĂᗁ᜕ ဥฤෞҤ׎វ˧ధΞĂགྷϤВТ੅ኢăᏴፄ гᕇĂ౅࿅ྎ௟ఢထྮቢĂ኎ିछᛳღާ఍ நନ߉ĂםӄԆјБछҌҘ̄៉΍ྼ۞͕ ᙸĄ 8. 4/18щଵ९؍ᄃ࣎९дщᐖ̈́൑ˠ̒ᕘଐဩ ˭ࢬ၆ࢬ໛఼ă੅ኢ׊̃ϏֽϠ߿໰᜕Ą 9. 4/19੫၆়ঽซणĂᗁ᜕ဥฤΡฟछलົ ᛉĂᄃ࣎९̈́छᛳྋᛖ়ঽត̼͔֭ጱםᛉ ޢְ໤౯̈́ޢᜈ໰᜕͞ШĄ 10.4/8-4/19ົТ؟ିर࿵ળҢགྷăΐஎܫЈໄ هĂͽα؞ϠၗࠎּĂឰ࣎९˞ྋ༱ۏ࠰ѣ хдᆊࣃĂ҃ϠҁঽѪߏҋ൒ೈᒖ۞˘ొ ̶ćᖣϤିጱᄪهҢགྷăೡᘱҢညĂͽπᐖ ͕ីĂΝੵѪ˸ऻᛵĄ 11.4/20ᄃۤ̍ВТග̟࣎९̈́छᛳᓜ௣ݖ๋͕ ந͚޺̈́አዋćͷᄃ࣎९ВТౖҡ९̄Ăᖣ Ϥᘱဦܑ྿׎၆Ѫ˸ऻᛵ࠻ڱĂ֭ዋॡග̟ ͕நᅃጱĄ 12.4/21щଵ࣎९ᄃछᛳҌםኘވĂᒉౄщᐖă ᔳռᄃ፾ϲ۩มᒖဩֹ࣎९Ϲ΃᏷ឤĂТॡ ВТ੅ኢăᏴፄ໤౯ـϠॡஐ֗۞җۏ׶໰ ͯĂ֭Ϲ΃֗ޢְĂᒉౄ྽ҾଐဩĄ 13.4/23؟ିर೩ֻ࣎९ᄃछᛳޢְ໤౯࠹ᙯྤ ੈăཨᆇۤᓑᘭ̈́ࠀኘӄهְآĄ 1. 4/15࣎९Ш९؍ܑ ϯĶͽ݈ຑኯ౾ͷ ̙࢑యЇޝ၆̙੓ ҰࣇĂҭԧߏຑҰ ࣇ ۞ ķĂ ౅ ࿅ ͹ જ ጾٱăϡᐠ̈́ٮᛷ ໰ͯ͞ёĂ࣒ೇछ ˠكѩมᙯܼĂ࠹ ఍࿅඀ᏉࠀĄ 2. 4/17ᄃछˠҌҘ̄ ៉΍ྼĂܔੰޢ͹ ෦͕ᙸԆјĄ 3. 4/20࣎९ᙸຍึڇ Ңয়Ѫ˸щଵĂͷ ၆ӈ૟ـϠਕ؃൒ ତצć׎ܑଐே׶ ͹෦ĶՏ࣎ˠϠ˭ ֽౌߏѣЇચ۞Ă னдԧдˠ͵ม۞ Їચ̏གྷԆјĂְ ଐ˵ౌϹ΃р˞Ă ࡶҢয়ֽତĂΞͽ щ͕ᗓฟĄķ 4-1.4/22࣎९Ӏϡᐂ ࢰ͞ёϹ΃᏷ឤĂ Тॡᄃ९؍ᓑᘭཨ ᆇۤĂВТ੅ኢޢ ְ૟ͽҢିᆇёซ ҖĂ֭ࠀኘ࠹ᙯְ ี௟༼఍நĄ 4-2.4/24˯̾࣎९ຍ ᙊӔனڃਜ਼Ă؟ି र಴ࢦ࣎९୻ᏹॡ ຍ ᙸ Ă ֹ ϡ ቷ ܅ ळă៍ࢰည̈́ᇫٸ Ң ି ࢰ ሄ ᄪ གྷ ӄ ળć˭̾࣎९ـϠ ॡᗁᒚဥฤјࣶБ ඀ౖҡĂֹ࣎९̈́ छᛳצז಴ࢦĂ֭ ఍дே׶҃ఄᚑᒖ ဩ̚Ą

(9)

Ղพර(2004)Ćᒛϐঽଈ۞ۤົ͕நېၗᄃ໰ ᜕Ćٺᜪ˜πඈᓁ७ዦĂщှቤ׶᜕நጯ (pp. 474-491)Ćέ̚Ĉරॾ֤Ą Նځጙ(2004)Ćኘីّ໰ᜪĆ᜕நᗔᄫĂ51(5)Ă 78-83Ą ܭ୿ࡻăᛂͽܦăᖡළ୥(2004)Ćྻϡҋԧۺؠ ੊ቚЪ׀ᄮۢڼᒚٺԼචܝ෧˘ҜҲҋ಴ ࣎९᜕̝நགྷរĆ᜕நᗔᄫĂ51(2) Ă97-103Ą ੼ࡔ೎(2005)Ć᜕ந෧ᕝ͘Ί2005-2006ĆέΔĈ රՃĄ गလࠠăૺ̮࢐ăԇ୥Ϡăเ࡚༉ăͳսࢶă ో৵ܦ(2004)Ć۾ࢶᒚڱٺᒛাঽଈ̝ྻ ϡĆщှᒚ᜕ᗔᄫĂ9(3)Ă253-263Ą ధ໴զ(2004)ĆᅃӄᄃΩᙷᗁጯᖎ̬Ćщှᒚ᜕ ᗔᄫĂ9(3)Ă264-275Ą ౘᇉዶ(2004)Ćᒛϐঽˠώ˿̼ីّ໰ᜪሀёĆ έ៉ᗁጯĂ8(5)Ă664-671Ą ౘِт(2006)Ćϐഇঽˠ۞ីّᅮՐᄃីّ໰ ᜪĆຎᑻᗁጯĂ18(4)Ă61-66Ą ૺ ೎ Ⴖ ă ᆒ ፍ ۘ ă Ղ ֶ ৷ ă ౘ ལ ۾ ă ׹ ૈ ལ (2006)ĆϱҜ޷ᇝᓜԖ᜕நྻϡ̝͛ᚥа ᜪĆܜഇ໰᜕ᗔᄫĂ10(1)Ă91-101Ą เശබ(2003)Ćᒛাঽଈ۞ূ൭ᄃԓ୕඀ޘ̝࠹ ᙯّࡁտĆܜطࡊԫጯΏĂ2Ă113-128Ą เ щ ѐ ă ౘ к ᇍ ă ୖ Ѻ щ ă അ ᇉ ິ ă ᐼ ှ ⚻ (2003)ĆᘓѪঽଈ̝ূ൭ڼᒚĆщှᒚ᜕ᗔ ᄫĂ8(3)Ă283-298Ą ችᚊำ(2004)Ćূ൭યᗟᄃ໰᜕Ćٺᜪ˜πඈᓁ ७ዦĂщှቤ׶᜕நጯ(pp. 153-212)Ćέ ̚Ĉරॾ֤Ą ᛂ̈බăౘݡࠠăᏥ̯ܪăڒָᐖ(2004)Ćщှ ᒚ᜕ূ൭఍ཉણ҂޽͔ٺᒛϐঽଈֹϡј ड़̝አߤĆၷᓁ᜕நĂ21(4)Ă363-374Ą Albinsson, L., & Strang, P. (2002). A Palliative

approach to existential issues and death in endstage dementia care. Journal of Palliative Care, 18(3), 168-174.

Galek, K., Flannely, K. J., Vane, A., & Galek, R. M. (2005). Assessing a Patient’s spiritual needs. Holistic Nursing Practice, 19(2), 62-69. Hunt, J., Cobb, M., Keeley, V. L., & Ahmedzai, S.

H. (2003). The quality of spiritual care-developing a standard. International Journal of Palliative Nursing, 9(5), 208-215.

(10)

ABSTRACT

This report described the nursing experience of a terminal liver cancer patient who has obtained physical, psychological, and spiritual care experiences after hospice care. The author assessed physical, psychological, and spiritual aspects of the case by the ways of physical assessment, conversation, listening, observing family dynamics, hospice team care, and Roy Adaptation Model. Chronic pain, situational low self-esteem, and spiritual distress health problems were identified for the case. Nursing interventions for the case is to release his pain indicators through non-traditional pain-killer medicines and assist him to complete daily life activities by limited energy and function. Through the intervention process, the case’s self-esteem has been promoted so that he could search for the meaning of illness and pain by the way of conversation, education, counseling, and life-reviewing gradually. Additionally, the case has experienced being forgiven by his wife and children, being able to forgive himself, appreciated the process of being loved and loved, and had the courage to face, accept, and prepare his own death. Through exploring the physical, psychological, and spiritual care experiences of the terminal liver cancer patient, the author suggested social workers can follow up the case’s family and release their grief responses after the case’s death by telephone calling, hospice home care of family members, and transferred into the supporting groups that could achieve the highest quality of care in the whole person, whole family, whole process, and whole team.

Key words: liver cancer, terminal patient, physical, psychological, spiritual care.

Physical, Psychological, and Spiritual Care

Experiences of a Terminal Patient

with Liver Cancer

Ching-Wen Hsu

ąYa-Lie Ku*

RN, Nurse of Hospice Care, Chang Gung Memorial Hospital, Kaohsiung, *RN, MSN, Assistant Professor, College of Nursing, Fooyin University.

Received: September 7, 2007 Revised: October 29, 2007 Accepted: November 1, 2007

Address correspondence to: Ching-Wen Hsu, School of Nursing, Meiho Institute of Technology. No. 19, Lane 5, Shandong St., Sanmin District, Kaohsiung City 80758, Taiwan, R.O.C. Tel.: 886-7-3162409; E-mail: joan1012.@yahoo.com.tw

參考文獻

相關文件

˙Please visit the Outpatient Clinic of Family Please visit the Outpatient Clinic of Family Medicine Division for a follow-up diagnosis and

In order to apply for a permit to employ Class B Foreign Worker(s), an Employer shall provide reasonable employment terms and register for such employment demands with local

Should an employer find it necessary to continue the employment of the Class A Foreign Worker(s), the employer shall, within four (4) months prior to the expiration of the

了⼀一個方案,用以尋找滿足 Calabi 方程的空 間,這些空間現在通稱為 Calabi-Yau 空間。.

Wang, Solving pseudomonotone variational inequalities and pseudocon- vex optimization problems using the projection neural network, IEEE Transactions on Neural Networks 17

volume suppressed mass: (TeV) 2 /M P ∼ 10 −4 eV → mm range can be experimentally tested for any number of extra dimensions - Light U(1) gauge bosons: no derivative couplings. =>

Define instead the imaginary.. potential, magnetic field, lattice…) Dirac-BdG Hamiltonian:. with small, and matrix

• Formation of massive primordial stars as origin of objects in the early universe. • Supernova explosions might be visible to the most